例如:"NBL1", "4681", "drought"
收藏
11334 TUSC2

11334

TUSC2

tumor suppressor 2, mitochondrial calcium regulator

protein-coding

Homo sapiens

基因描述

Type Description
Definition tumor suppressor 2, mitochondrial calcium regulator

研究结论

Date Results Publications
2020-11-21 13:16:00 The TUSC2 Inhibits the Malignant Phenotype of Human Thyroid via SMAC/DIABLO Protein. 31973107
2020-10-24 13:56:00 MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression. 31481748
2019-08-24 13:03:00 Low TUSC2 expression is associated with bladder cancer. 30896880
2018-11-10 12:00:00 TUSC2P can suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and may also serve as a prognostic factor for esophageal squamous cell carcinoma patients. 30219035
2018-04-28 10:14:00 these findings show that the combination of TUSC2-erlotinib induces additional novel vulnerabilities that can be targeted with Auranofin. 27845352

名称对应

Type IDs
Synonymous C3orf11, FUS1, PAP, PDAP2
Gene
UniProtKB-ID: TUSC2_HUMAN
UniprotKB: O75896
UniParc: UPI000012AD8D
EMBL: AK311998, BC023976, CH471055, AF055479
Ensembl: ENSG00000114383
KO: hsa:11334
Nucleutide sequences
EMBL-CDS: BAG34936.1, AAH23976.1, EAW65097.1, AAC35497.1
Ensembl_TRS: ENST00000232496
Protein sequencees
Ensembl_PRO: ENSP00000232496
RefSeq: NP_009206.1
Others
UniRef100: UniRef100_O75896
UniRef90: UniRef90_O75896
UniRef50: UniRef50_O75896
UniGene: Hs.517981
CCDS: CCDS2819.1

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员